Whole-body MRI versus an FDG-PET/CT-based reference standard for staging of paediatric Hodgkin lymphoma: a prospective multicentre study.


Journal

European radiology
ISSN: 1432-1084
Titre abrégé: Eur Radiol
Pays: Germany
ID NLM: 9114774

Informations de publication

Date de publication:
Mar 2021
Historique:
received: 23 03 2020
accepted: 11 08 2020
revised: 02 06 2020
pubmed: 4 9 2020
medline: 15 4 2021
entrez: 4 9 2020
Statut: ppublish

Résumé

To assess the concordance of whole-body MRI (WB-MRI) and an FDG-PET/CT-based reference standard for the initial staging in children with Hodgkin lymphoma (HL) METHODS: Children with newly diagnosed HL were included in this prospective, multicentre, international study and underwent WB-MRI and FDG-PET/CT at staging. Two radiologists and a nuclear medicine physician independently evaluated all images. Discrepancies between WB-MRI and FDG-PET/CT were assessed by an expert panel. All FDG-PET/CT errors were corrected to derive the FDG-PET/CT-based reference standard. The expert panel corrected all reader errors in the WB-MRI DWI dataset to form the intrinsic MRI data. Inter-observer agreement for WB-MRI DWI was calculated using overall agreement, specific agreements and kappa statistics. Concordance for correct classification of all disease sites and disease stage between WB-MRI (without DWI, with DWI and intrinsic WB-MRI DWI) and the reference standard was calculated as primary outcome. Secondary outcomes included positive predictive value, negative predictive value and kappa statistics. Clustering within patients was accounted for using a mixed-effect logistic regression model with random intercepts and a multilevel kappa analysis. Sixty-eight children were included. Inter-observer agreement between WB-MRI DWI readers was good for disease stage (κ = 0.74). WB-MRI DWI agreed with the FDG-PET/CT-based reference standard for determining disease stage in 96% of the patients versus 88% for WB-MRI without DWI. Agreement between WB-MRI DWI and the reference standard was excellent for both nodal (98%) and extra-nodal (100%) staging. WB-MRI DWI showed excellent agreement with the FDG-PET/CT-based reference standard. The addition of DWI to the WB-MRI protocol improved the staging agreement. • This study showed excellent agreement between WB-MRI DWI and an FDG-PET/CT-based reference standard for staging paediatric HL. • Diffusion-weighted imaging is a useful addition to WB-MRI in staging paediatric HL. • Inter-observer agreement for WB-MRI DWI was good for both nodal and extra-nodal staging and determining disease stage.

Identifiants

pubmed: 32880696
doi: 10.1007/s00330-020-07182-0
pii: 10.1007/s00330-020-07182-0
pmc: PMC7880958
doi:

Substances chimiques

Fluorodeoxyglucose F18 0Z5B2CJX4D

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1494-1504

Subventions

Organisme : Stichting Kinderen Kankervrij
ID : 87

Références

CA Cancer J Clin. 2014 Mar-Apr;64(2):83-103
pubmed: 24488779
AJR Am J Roentgenol. 2001 Feb;176(2):289-96
pubmed: 11159059
Oncotarget. 2017 Sep 14;8(45):78261-78262
pubmed: 29108225
J Clin Oncol. 2014 Sep 20;32(27):3048-58
pubmed: 25113771
JAMA Pediatr. 2013 Aug 1;167(8):700-7
pubmed: 23754213
Radiology. 2015 Aug;276(2):323-38
pubmed: 26203705
Eur J Nucl Med Mol Imaging. 2008 Aug;35(8):1581-8
pubmed: 18536914
BMJ. 2013 Apr 12;346:f2125
pubmed: 23585065
Chin Clin Oncol. 2015 Mar;4(1):5
pubmed: 25841712
Eur Radiol. 2019 Jan;29(1):202-212
pubmed: 29948084
Eur J Radiol. 2016 Feb;85(2):313-8
pubmed: 26781135
Radiology. 2010 Apr;255(1):182-90
pubmed: 20308456
J Clin Oncol. 2014 Sep 20;32(27):3059-68
pubmed: 25113753
Eur Radiol. 2014 May;24(5):1153-65
pubmed: 24563179
Eur J Radiol. 2019 Dec;121:108737
pubmed: 31734638
MAGMA. 2019 Jun;32(3):381-390
pubmed: 30498885
Eur J Nucl Med Mol Imaging. 2013 Feb;40(3):373-85
pubmed: 23197155
Blood. 2012 Sep 13;120(11):2195-202
pubmed: 22826564
Semin Nucl Med. 2017 May;47(3):242-257
pubmed: 28417854
Invest Radiol. 2009 Oct;44(10):683-90
pubmed: 19724232
Klin Padiatr. 2013 Nov;225(6):357-61
pubmed: 24166093
Arch Intern Med. 2009 Dec 14;169(22):2078-86
pubmed: 20008690
J Magn Reson Imaging. 2015 Jun;41(6):1601-7
pubmed: 25111444
Radiology. 2014 Oct;273(1):220-31
pubmed: 24877983
Pediatr Radiol. 2006 Sep;36 Suppl 2:121-5
pubmed: 16862418
Biom J. 2017 Sep;59(5):1016-1034
pubmed: 28464322
Acta Radiol. 2011 Mar 1;52(2):173-80
pubmed: 21498346
Biometrics. 1977 Mar;33(1):159-74
pubmed: 843571

Auteurs

Suzanne Spijkers (S)

Department of Radiology and Nuclear Medicine, University Medical Center Utrecht/Wilhelmina Children's Hospital, Utrecht University, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands. suzannespijkers@outlook.com.

Annemieke S Littooij (AS)

Department of Radiology and Nuclear Medicine, University Medical Center Utrecht/Wilhelmina Children's Hospital, Utrecht University, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.
Princess Máxima Center for Paediatric Oncology, Utrecht, The Netherlands.

Thomas C Kwee (TC)

Medical Imaging Center, Department of Radiology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.

Nelleke Tolboom (N)

Department of Radiology and Nuclear Medicine, University Medical Center Utrecht/Wilhelmina Children's Hospital, Utrecht University, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.
Princess Máxima Center for Paediatric Oncology, Utrecht, The Netherlands.

Auke Beishuizen (A)

Princess Máxima Center for Paediatric Oncology, Utrecht, The Netherlands.
Department of Paediatric Oncology/Haematology, Erasmus Medical Center-Sophia Children's Hospital, Rotterdam, The Netherlands.

Marrie C A Bruin (MCA)

Princess Máxima Center for Paediatric Oncology, Utrecht, The Netherlands.

Sjoerd G Elias (SG)

Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

Tim van de Brug (T)

Department of Epidemiology and Biostatistics, Amsterdam University Medical Centers, VUmc, Amsterdam, The Netherlands.

Goya Enríquez (G)

Institut de Recerca Vall d'Hebron, Barcelona, Spain.

Constantino Sábado (C)

Department of Paediatric Oncology and Haematology, University Hospital Vall d'Hebron, Barcelona, Spain.

Elka Miller (E)

Department of Medical Imaging, CHEO, University of Ottawa, Ottawa, Canada.

Claudio Granata (C)

Department of Paediatric Radiology, Institute for Maternal and Child Health IRCCS Burlo Garofolo, Trieste, Italy.

Charlotte de Lange (C)

Department of Diagnostic Imaging and Intervention, Oslo University Hospital, Rikshospitalet, Oslo, Norway.

Federico Verzegnassi (F)

Oncohematology Unit, Institute for Maternal and Child Health IRCCS Burlo Garofolo, Trieste, Italy.

Mary-Louise C Greer (MC)

Department of Diagnostic Imaging, The Hospital for Sick Children, Department of Medical Imaging, University of Toronto, Toronto, Ontario, Canada.

Bart de Keizer (B)

Department of Radiology and Nuclear Medicine, University Medical Center Utrecht/Wilhelmina Children's Hospital, Utrecht University, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.
Princess Máxima Center for Paediatric Oncology, Utrecht, The Netherlands.

Rutger A J Nievelstein (RAJ)

Department of Radiology and Nuclear Medicine, University Medical Center Utrecht/Wilhelmina Children's Hospital, Utrecht University, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.
Princess Máxima Center for Paediatric Oncology, Utrecht, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH